Literature DB >> 24653586

Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?

Sobia Mujtaba1, Jorge Romero2, Cynthia C Taub3.   

Abstract

Methadone is a drug that has found widespread utility in the management of opioid addiction and pain. Along with its popularity, methadone has also earned an infamous reputation for causing prolongation of the QT interval and an increased risk of torsades de pointes. In this article we will give a brief overview of the long QT syndromes, followed by an in-depth look at the current pathophysiologic mechanisms of methadone induced QT prolongation, a review of the existing literature and the current concepts regarding the prevention and management of methadone induced torsades de pointes. In addition, we explore the idea and implications of a genetic link between methadone induced prolongation of the QT interval and torsades de pointes.

Entities:  

Keywords:  Methadone; Pharmacogenetics; QT-prolongation; Torsades de pointes

Year:  2013        PMID: 24653586      PMCID: PMC3953689          DOI: 10.1016/j.jcdr.2013.10.001

Source DB:  PubMed          Journal:  J Cardiovasc Dis Res        ISSN: 0975-3583


  48 in total

1.  Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study.

Authors:  Olav Magnus S Fredheim; Petter C Borchgrevink; Lars Hegrenaes; Stein Kaasa; Ola Dale; Pål Klepstad
Journal:  J Pain Symptom Manage       Date:  2006-08       Impact factor: 3.612

2.  Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.

Authors:  Einat Peles; Gershon Bodner; Mary Jeanne Kreek; Vera Rados; Miriam Adelson
Journal:  Addiction       Date:  2007-02       Impact factor: 6.526

3.  Anti-cholinesterase activity of 1-alpha-acetylmethadol: relationship to bradycardia.

Authors:  D C Eikenburg; J L Stickney
Journal:  Gen Pharmacol       Date:  1979

4.  Electrocardiographic changes in heroins, methadone and multiple drug abuse: a postulated mechanism of sudden death in narcotic addicts.

Authors:  B Stimmel; J Lipski; M Swartz; E Donoso
Journal:  Proc Natl Conf Methadone Treat       Date:  1973

5.  Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.

Authors:  Alexander N Katchman; Kelly A McGroary; Michael J Kilborn; Craig A Kornick; Paolo L Manfredi; Raymond L Woosley; Steven N Ebert
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

Review 6.  Methadone--metabolism, pharmacokinetics and interactions.

Authors:  Anna Ferrari; Ciro Pio Rosario Coccia; Alfio Bertolini; Emilio Sternieri
Journal:  Pharmacol Res       Date:  2004-12       Impact factor: 7.658

7.  Calcium channel blockade by certain opioids.

Authors:  D E Seyler; J L Borowitz; R P Maickel
Journal:  Fundam Appl Toxicol       Date:  1983 Nov-Dec

8.  Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study.

Authors:  Christopher Newton-Cheh; Chao-Yu Guo; Martin G Larson; Stacy L Musone; Aarti Surti; Amy L Camargo; Jared A Drake; Emelia J Benjamin; Daniel Levy; Ralph B D'Agostino; Joel N Hirschhorn; Christopher J O'donnell
Journal:  Circulation       Date:  2007-08-20       Impact factor: 29.690

9.  Low penetrance in the long-QT syndrome: clinical impact.

Authors:  S G Priori; C Napolitano; P J Schwartz
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

10.  Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.

Authors:  Søren Fanoe; Christian Hvidt; Peter Ege; Gorm Boje Jensen
Journal:  Heart       Date:  2007-03-07       Impact factor: 5.994

View more
  11 in total

Review 1.  Pharmacogenetics of Methadone Response.

Authors:  Francina Fonseca; Marta Torrens
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

Review 2.  Pharmacogenomics of methadone: a narrative review of the literature.

Authors:  Senthil Packiasabapathy; Blessed W Aruldhas; Nicole Horn; Brian R Overholser; Sara K Quinney; Janelle S Renschler; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2020-07-24       Impact factor: 2.533

3.  Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women.

Authors:  Debra L Bogen; Barbara H Hanusa; James M Perel; Frederick Sherman; Marla A Mendelson; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

4.  Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?

Authors:  Jorge Romero; Samuel H Baldinger; David Goodman-Meza; Krysthel Engstrom; Carolina R Valencia; Anjani Golive; Francisco Medrano; Sabarivinoth Rangasamy; Mohammed Makkiya; John D Fisher; Jay Gross; Andrew Krumerman; Soo Kim; Mario J Garcia; Luigi Di Biase; Kevin J Ferrick
Journal:  J Interv Card Electrophysiol       Date:  2015-11-20       Impact factor: 1.900

Review 5.  Restless Legs Syndrome: Contemporary Diagnosis and Treatment.

Authors:  Thomas R Gossard; Lynn Marie Trotti; Aleksandar Videnovic; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-04-20       Impact factor: 7.620

6.  QT Interval Prolongation in the Pediatric Oncologic Population on Methadone.

Authors:  Jenna A Piccininni; James S Killinger; Hoda T Hammad; Linda M Gerber; Jeffrey D Dayton
Journal:  J Pediatr Hematol Oncol       Date:  2020-03       Impact factor: 1.170

Review 7.  The anti-addiction drug ibogaine and the heart: a delicate relation.

Authors:  Xaver Koenig; Karlheinz Hilber
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

8.  Characterizing QT interval prolongation in early clinical development: a case study with methadone.

Authors:  Vincent F S Dubois; Meindert Danhof; Oscar Della Pasqua
Journal:  Pharmacol Res Perspect       Date:  2017-01-24

9.  Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.

Authors:  Miaoying Shi; Hans Bouwmeester; Ivonne M C M Rietjens; Marije Strikwold
Journal:  Arch Toxicol       Date:  2020-05-04       Impact factor: 5.153

10.  Is high sensitive-troponin I a reliable biomarker for cardiac injury in methadone toxicity? A prospective cross-sectional study.

Authors:  Hasan Shemirani; Masoumeh Sadeghi; Azadeh Davoudian Dehkordi; Farzad Gheshlaghi
Journal:  BMC Pharmacol Toxicol       Date:  2022-03-23       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.